Delivery Order SPE2DX22D0049-SPE2D826FA1MB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,960.16 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order, to be completed by August...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 24, 2025, valued at $1,348.98 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as a non-competitive award, has a completion date of September 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,756.24 by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025. The contract, which represents a child order under a larger indefinite delivery vehicle, involves firm fixed pricing with no set-aside designation and an ultimate completion date of September 19, 2025. As a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,355.40 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,160.99 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a child award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,251.32 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by September 22, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA1MBDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,039,131.66 on November 13, 2025, with a completion date of November 14, 2025. This Firm Fixed Price delivery order, issued without set-aside designation, falls under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order represents a child contract action supporting the Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. Under this delivery order, AmerisourceBergen supplies pharmaceutical products and medical supplies from its comprehensive portfolio, which includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract awards demonstrate extensive capability in delivering critical medical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm's selection through competitive procurement reflects its established capacity to meet federal medical procurement requirements and serve as a prime vendor for the department's global pharmaceutical support needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0m | 11/13/25 |